Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 7
2019 3
2020 6
2021 7
2022 21
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
[Lynch syndrome: What is new?].
Pellat A, Netter J, Perkins G, Cohen R, Coulet F, Parc Y, Svrcek M, Duval A, André T. Pellat A, et al. Bull Cancer. 2019 Jul-Aug;106(7-8):647-655. doi: 10.1016/j.bulcan.2018.10.009. Epub 2018 Dec 4. Bull Cancer. 2019. PMID: 30527816 Free article. Review. French.
Tumor microenvironment: A new application for radiomics.
Pellat A, Barat M. Pellat A, et al. Diagn Interv Imaging. 2023 Mar;104(3):93-94. doi: 10.1016/j.diii.2022.10.011. Epub 2022 Oct 29. Diagn Interv Imaging. 2023. PMID: 36880939 Free article. No abstract available.
[NTRK Fusions: A new way of treatment for gastro-intestinal tumor?].
Ouali K, Pellat A, Cohen R, Svrcek M, Penault-Llorca F, André T. Ouali K, et al. Among authors: pellat a. Bull Cancer. 2020 Apr;107(4):447-457. doi: 10.1016/j.bulcan.2019.11.014. Epub 2020 Feb 14. Bull Cancer. 2020. PMID: 32067719 Review. French.
[Radiation therapy in patients with inflammatory bowel disease. A review].
Jmour O, Pellat A, Colson-Durand L, To NH, Latorzeff I, Sargos P, Sobhani I, Belkacemi Y. Jmour O, et al. Among authors: pellat a. Bull Cancer. 2018 May;105(5):517-522. doi: 10.1016/j.bulcan.2018.02.005. Epub 2018 Apr 10. Bull Cancer. 2018. PMID: 29653817 Review. French.
Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting.
Falette-Puisieux M, Nault JC, Bouattour M, Lequoy M, Amaddeo G, Decaens T, Di Fiore F, Manfredi S, Merle P, Baron A, Locher C, Pellat A, Coriat R. Falette-Puisieux M, et al. Among authors: pellat a. Ther Adv Med Oncol. 2023 Aug 1;15:17588359231189425. doi: 10.1177/17588359231189425. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37547443 Free PMC article.
54 results